| Study to Evaluate the Effect of Filgotinib on Semen Parameters in Adult Males With Active Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, or Non-radiographic Axial Spondyloarthritis (NCT03926195) | Lakefront Biotherapeutics NV | 2019-05-28 |
| PROM Collected Via a Smartphone App Versus a Touch Screen Solution Among Patients With Inflammatory Arthritis (NCT03486613) | Salome Kristensen | 2019-04-24 |
| Psoriatic Oligoarthritis Intervention With Symptomatic thErapy (NCT03797872) | University of Oxford | 2019-04-17 |
| Metabolic Syndrome in Psoriasis and Psoriatic Arthritis and Correlation With Serum Omentin and Visfatin Levels (NCT03932110) | Istanbul Medeniyet University | 2019-04-15 |
| Apremilast in Psoriatic Arthritis in Real-life Clinical Practice in Greece (NCT03780504) | Genesis Pharma S.A. | 2019-04-15 |
| The Effect of Psoriatic Arthritis on the Functions of the Hand (NCT04540809) | Inonu University | 2019-04-15 |
| A Study to Test the Efficacy and Safety of Bimekizumab in the Treatment of Subjects With Active Psoriatic Arthritis (NCT03895203) | UCB Biopharma SRL | 2019-04-03 |
| A Study to Evaluate the Efficacy and Safety of Bimekizumab in the Treatment of Subjects With Active Psoriatic Arthritis (NCT03896581) | UCB Biopharma SRL | 2019-03-28 |
| A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Have a History of Inadequate Response to or Intolerance to at Least One Disease Modifying Anti-Rheumatic Drug (DMARD) Therapy (NCT03675308) | AbbVie | 2019-03-25 |
| Carpal Tunnel Syndrome in Patients With Psoriatic Arthritis (NCT05086029) | Selcuk University | 2019-03-20 |
| EBIO - Enthesitis Biopsy Study (NCT04887597) | University of Erlangen-Nürnberg Medical School | 2019-03-18 |
| Carpal Tunnel Syndrome in Patients With Psoriatic Arthritis; Ultrasonography and Magnetic Resonance Imaging Findings (NCT05086042) | Selcuk University | 2019-03-15 |
| Changes in Body Composition Under Ustekinumab in PsA (NCT03823924) | University Hospital, Lille | 2019-03-11 |
| Therapeutic Strategy Associated With bDMARDs or tsDMARDs in Rheumatoid Arthritis and Psoriatic Arthritis (NCT05082805) | Nordic Pharma SAS | 2019-02-25 |
| Ultrasound Enthesitis Response in Psoriatic Arthritis (NCT03955861) | Belfast Health and Social Care Trust | 2019-02-14 |
| A Study to Evaluate the Impact of Apremilast on Magnetic Resonance Imaging (MRI) Outcomes in Adults With Psoriatic Arthritis (NCT03783026) | Amgen | 2019-02-06 |
| The Risk of Venous Thromboembolism in Systemic Inflammatory Disorders: a United Kingdom (UK) Matched Cohort Study (NCT03835780) | Momentum Data | 2019-02-01 |
| Treatment Goals in Psoriatic Arthritis (NCT03620188) | Johns Hopkins University | 2018-12-20 |
| Danish Population-based Assessment of Psoriasis and Psoriatic Arthritis (DANPAPP) (NCT04515732) | Professor Mikkel Østergaard | 2018-12-14 |
| Psoriatic Arthritis and Psoriasis Treatment Decision Aid (NCT03737045) | University of Pennsylvania | 2018-12-01 |
| CBD Treatment in Hand Osteoarthritis and Psoriatic Arthritis. (NCT03693833) | Aalborg University Hospital | 2018-11-28 |
| microRNA in Erosive Hand Osteoarthritis and Psoriatic Arthritis (NCT05683769) | University of Siena | 2018-09-01 |
| Efficacy And Safety Of Tofacitinib In Chinese Subjects With Active Psoriatic Arthritis (NCT03486457) | Pfizer | 2018-08-10 |
| Clinical Study of Efficacy and Safety of BCD-085 (Monoclonal Anti-IL-17 Antibody) in Psoriatic Arthritis (NCT03598751) | Biocad | 2018-07-25 |
| Clinical Impact of Acthar in the Psoriatic Arthritis Patient (CLIPS) (NCT03419650) | IRIS Research and Development, LLC | 2018-07-20 |
| Post Market Clinical Follow-up (PMCF) Study of the A.L.P.S. Proximal Humerus Plating System (NCT03626038) | Zimmer Biomet | 2018-06-19 |
| Multicentre ObservatioNal Initiative in Treat to Target Outcomes in Psoriatic Arthritis (NCT03531073) | University of Oxford | 2018-04-18 |
| Early Biomarkers for ARthritic PAIN to Guide Improved Treatments for Arthritis (NCT03533569) | St George's, University of London | 2018-04-02 |
| Investigating the Utilisation and Effectiveness of Originator and Biosimilar Anti-TNF Agents (NCT03470688) | Opal Rheumatology Ltd. | 2018-03-01 |
| A Study With a Initial Treatment Period Followed by a Randomized-withdrawal Period to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis (NCT03410992) | UCB Biopharma SRL | 2018-02-05 |
| Mindfulness Based Stress Reduction in Rheumatic Diseases (NCT03411057) | Johns Hopkins University | 2018-01-18 |
| A Study to Investigate BMS-986165 and Methotrexate in Healthy Male Patients (NCT03402087) | Bristol-Myers Squibb | 2018-01-08 |
| Psoriatic Arthritis Research Collaborative: Biologic Sub-Study (NCT03378336) | University of Pennsylvania | 2017-12-31 |
| Patterns After Administration of MCFAs in Psoriasis and Psoriatic Arthritis (NCT03409211) | NYU Langone Health | 2017-12-12 |
| A Study to Evaluate the Long-Term Safety and Efficacy of Bimekizumab in Subjects With Psoriatic Arthritis (NCT03347110) | UCB Biopharma SRL | 2017-11-22 |
| Impact of AbbVie Care Patient Support Program on Clinical, Health Economic and Patient Reported Outcomes, in Crohn's Disease, Ulcerative Colitis, Rheumatoid Arthritis, Psoriatic Arthritis, Psoriasis and Axial Spondyloarthritis, in the Portuguese National Health Service (NCT03223012) | AbbVie | 2017-11-15 |
| Sonographic Analysis of Nails in Psoriatic Arthritis and Healthy Controls (NCT04718428) | Marmara University | 2017-10-14 |
| Safety and Efficacy of Tofacitinib vs Methotrexate in the Treatment of Psoriatic Arthritis (NCT03736161) | Globe Pharmaceuticals Limited | 2017-09-15 |
| A Study of Ixekizumab (LY2439821) Versus Adalimumab in Participants With Psoriatic Arthritis (NCT03151551) | Eli Lilly and Company | 2017-08-24 |
| Immune-Competent Cell Manifestations in Psoriatic Arthritis Achilles Tendons (NCT03248284) | Odense University Hospital | 2017-08-21 |
| An Open-label, Long-term Extension Study With Filgotinib in Active Psoriatic Arthritis. (NCT03320876) | Lakefront Biotherapeutics NV | 2017-07-26 |
| Pharmacist CVD Intervention for Patients With Inflammatory Arthritis (NCT03152396) | Epidemiology Coordinating and Research Centre, Canada | 2017-07-17 |
| Immune Metabolic Associations in Psoriatic Arthritis (NCT03399708) | NHS Greater Glasgow and Clyde | 2017-06-12 |
| Remission and Flare in Psoriatic Arthritis: a Prospective 6-month Study With a Double Perspective. (NCT03119805) | Groupe Hospitalier Pitie-Salpetriere | 2017-05-18 |
| Efficacy and Safety of Fecal Microbiota Transplantation in Peripheral Psoriatic Arthritis (NCT03058900) | Odense University Hospital | 2017-05-16 |
| A Study Comparing Upadacitinib (ABT-494) to Placebo in Participants With Active Psoriatic Arthritis Who Have a History of Inadequate Response to at Least One Biologic Disease Modifying Anti-Rheumatic Drug (NCT03104374) | AbbVie | 2017-05-01 |
| A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Participants With Psoriatic Arthritis Who Have an Inadequate Response to at Least One Non-Biologic Disease Modifying Anti-Rheumatic Drug (DMARD) (NCT03104400) | AbbVie | 2017-04-27 |
| Efficacy of Secukinumab Compared to Adalimumab in Patients With Psoriatic Arthritis (NCT02745080) | Novartis Pharmaceuticals | 2017-04-03 |
| A Study to Assess Efficacy and Safety of Filgotinib in Active Psoriatic Arthritis (NCT03101670) | Lakefront Biotherapeutics NV | 2017-03-09 |
| The Norwegian Drug Monitoring Study (NCT03074656) | Diakonhjemmet Hospital | 2017-03-01 |
| DC-STAMP: Regulators of Osteoclastogenesis and Response Marker in PsA (NCT03011242) | University of Rochester | 2017-01-11 |
| A Study to Assess Retention Rate, Persistence and Adherence in Population of Spondylarthritis (Ankylosing Spondylitis and Psoriatic Arthritis) Patients Treated With Adalimumab in Routine Clinical Settings in Russian Federation (NCT02988674) | AbbVie | 2016-12-22 |
| Impact of Concomitant MTX on Efficacy, Safety and Adherence of Ustekinumab-treatment in Patients With Active PsA (NCT03148860) | Dr. Frank Behrens | 2016-12-15 |
| A Study to Investigate Safety With Risankizumab in Psoriatic Arthritis Subjects Who Have Completed Week 24 Visit of Study M16-002 (NCT02719171) (NCT02986373) | AbbVie | 2016-12-15 |
| National Observational Study On The Use Of Inflectra™ An Infliximab Biosimilar In Real Life (NCT02925338) | Pfizer | 2016-10-19 |
| Effect of Secukinumab in the Treatment of Psoriatic Arthritis (NCT02854163) | University of Liverpool | 2016-10-15 |
| A Study to Evaluate the Dose Response Based on the Efficacy, Safety and Tolerability of Bimekizumab in Subjects With Active Psoriatic Arthritis Which is a Type of Inflammatory Arthritis (NCT02969525) | UCB Biopharma S.P.R.L. | 2016-10-01 |
| CD73+ Th1.17 in Rheumatoid Arthritis and Psoriatic Arthritis (NCT03953378) | Hospices Civils de Lyon | 2016-09-01 |
| Study of Efficacy and Safety of Secukinumab in Psoriatic Arthritis and Axial Spondyloarthritis Patients With Active Enthesitis Including One Achilles Tendon Site (NCT02771210) | Novartis Pharmaceuticals | 2016-08-30 |
| Study of Power Doppler Ultrasound (PDUS) to Measure Response of Secukinumab Treatment in Patients With Active Psoriatic Arthritis (PsA) (NCT02662985) | Novartis Pharmaceuticals | 2016-08-22 |
| A Study of Subjects With Psoriatic Arthritis to Investigate the Effectiveness of Adalimumab Introduction Compared With Methotrexate Dose Escalation (CONTROL) (NCT02814175) | AbbVie | 2016-08-05 |
| A Phase 4 Clinical Study of Brodalumab (NCT04183881) | Kyowa Kirin Co., Ltd. | 2016-07-04 |
| Thermography in Assessing Treatment Response to Golimumab in Psoriatic Arthritis (NCT02841176) | Imperial College Healthcare NHS Trust | 2016-07-01 |
| Study to Evaluate the Safety and Efficacy of Secukinumab 300 mg and 150 mg in Adult Patients With Active Psoriatic Arthritis (PsA) After 16 Weeks of Treatment Compared to Placebo (NCT02798211) | Novartis Pharmaceuticals | 2016-06-27 |
| Korean Post-marketing Surveillance for Xeljanz (NCT02984020) | Pfizer | 2016-05-13 |
| Safety and Effectiveness of Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE Trial) (NCT02538341) | University of Alabama at Birmingham | 2016-05-01 |
| Post-marketing Observational Study to Evaluate the Incremental Impact of AbbVie's Patient Support Program on Patient Reported Outcomes and Health Resource Utilization in Inflammatory Arthritis, Psoriasis and Inflammatory Bowel Diseases in Hungary (VALUE) (NCT02750800) | AbbVie | 2016-04-07 |
| Effects of Weight-loss Treatment in Obese Patients With Psoriatic Arthritis (NCT02917434) | Vastra Gotaland Region | 2016-04-01 |
| Treatment With Apremilast in Patients With Psoriatic Arthritis (NCT02558361) | University of South Florida | 2016-04-01 |
| Frequency of Elevated Fecal Calprotectin Levels in Psoriatic Arthritis. (NCT04190108) | Hospital of Prato | 2016-01-02 |
| A Study on Assessment of STELARA and Tumor Necrosis Factor Alpha Inhibitor Therapies in Participants With Psoriatic Arthritis (NCT02627768) | Janssen Pharmaceutica N.V., Belgium | 2015-12-17 |
| GOLimumab and Methotrexate Versus Methotrexate in Very Early PsA (NCT04108468) | The Leeds Teaching Hospitals NHS Trust | 2015-10-27 |
| A Phase 2, Multicenter Open-Label Extension (OLE) Study With ABT-122 in Active Psoriatic Arthritis Subjects Who Have Completed a Preceding Study M14-197 (NCT02429895) | AbbVie | 2015-10-01 |
| A Long-Term Efficacy and Safety Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic Arthritis (NCT02584855) | Eli Lilly and Company | 2015-09-14 |
| Post-Marketing Use Of CT-P13 (Infliximab) For Standard Of Care Treatment Of Rheumatoid Diseases Who Are Naïve To Biologics Or Switched From Remicade (NCT02605642) | Pfizer | 2015-09-10 |
| Pain Mechanisms and Ultrasonographic Disease Activity in Psoriatic Arthritis (NCT02572700) | Frederiksberg University Hospital | 2015-09-01 |
| Assessment of Tender & Swollen Joints Count Score Performed by a Rheumatologist And Rheumatology Nurses in Patients With RA and PsA. (NCT02556034) | Isabelle Fortin | 2015-09-01 |
| Study to Demonstrate the Efficacy (Including Inhibition of Structural Damage), Safety and Tolerability up to 2 Years of Secukinumab in Active Psoriatic Arthritis (NCT02404350) | Novartis Pharmaceuticals | 2015-08-31 |
| Pregnancy and Medically Assisted Conception in Rare Diseases (NCT02450396) | Assistance Publique - Hôpitaux de Paris | 2015-06-01 |
| Research Study on the Immunosuppressive Effects of a Cell Therapy Product on PBMC Isolated From Blood of Patients With Inflammatory Rheumatic Diseases (NCT03454932) | Bone Therapeutics S.A | 2015-05-01 |
| Proof-of-concept Study of Forward Pharma (FP)187 in Patients With Mild/Moderate Psoriatic Arthritis (NCT02475304) | Skane University Hospital | 2015-05-01 |
| Identification of New Biomarkers to Promote Personalized Treatment of Patients With Inflammatory Rheumatic Diseases (NCT03214263) | Rigshospitalet, Denmark | 2015-05-01 |
| Identification of New Prognostic Markers in Psoriatic Arthritis (NCT03455166) | I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio | 2015-05-01 |
| A Phase 2 Study to Investigate the Safety, Tolerability and Efficacy of ABT-122 in Subjects With Active Psoriatic Arthritis (PsA) Who Have an Inadequate Response to Methotrexate (MTX) (NCT02349451) | AbbVie | 2015-04-28 |
| DC-STAMP & TRAF3: Regulators of Osteoclastogenesis and Biomarkers in PsA (NCT02413749) | University of Rochester | 2015-04-13 |
| Special Investigation in Patients With Psoriatic Arthritis (PsA) (Working Productivity and Activity Impairment [WPAI]) (NCT02414633) | AbbVie | 2015-04-01 |
| Efficacy and Safety Study of Guselkumab in the Treatment of Participants With Active Psoriatic Arthritis (PsA) (NCT02319759) | Janssen Research & Development, LLC | 2015-03-27 |
| A Study To Evaluate The Efficacy Of Enbrel (REGISTERED) Etanercept Over A Period Of 12 Months In The Routine Treatment Of Patients With Rheumatoid Arthritis, Axial Spondyloarthritis, Psoriatic Arthritis, Or Plaque Psoriasis. (NCT02486302) | Pfizer | 2015-03-24 |
| Etanercept and Methotrexate in Combination or as Monotherapy in Psoriatic Arthritis (NCT02376790) | Amgen | 2015-03-03 |
| PBR28 PET and Inflammatory Arthritis (NCT02361385) | University of Oxford | 2015-03-01 |
| A Study in Participants With Psoriatic Arthritis Attending Dermatology Clinics (NCT02470481) | Janssen Research & Development, LLC | 2015-03-01 |
| A Phase II Study Evaluating the Efficacy and Safety of AbGn-168H in Patients With Active Psoriatic Arthritis (NCT02267642) | AbGenomics B.V Taiwan Branch | 2015-01-01 |
| A Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic Arthritis (NCT02349295) | Eli Lilly and Company | 2014-12-31 |
| Apremilast Pregnancy Exposure Registry (NCT02775500) | University of California, San Diego | 2014-11-01 |
| Recirculating Memory T Cells in the Pathogenesis of Psoriatic Arthritis and Cutaneous Psoriasis (NCT03374527) | I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio | 2014-10-16 |
| The NOR-SWITCH Study (NCT02148640) | Diakonhjemmet Hospital | 2014-10-01 |
| A Multicenter, Postmarketing Study Evaluating the Concentration of Cimzia® in Mature Breast Milk of Lactating Mothers (NCT02154425) | UCB BIOSCIENCES, Inc. | 2014-09-01 |
| Efficacy of Golimumab in Combination With Methotrexate (MTX) Versus MTX Monotherapy, in Improving Dactylitis, in MTX naïve Psoriatic Arthritis Patients (NCT02065713) | Instituto de Medicina Molecular João Lobo Antunes | 2014-08-01 |
| Multiple Dose Study of UCB4940 in Subjects With Psoriatic Arthritis (NCT02141763) | UCB Celltech | 2014-05-01 |
| Evaluation of the Effectiveness of Resistance Training in Patients With Psoriatic Arthritis (NCT02598739) | Federal University of São Paulo | 2014-05-01 |